NCT04729153Unknown不适用
Impact of Previous Treatment of HCV Patients by DAADs on Covid-19 Disease Frequency and Severity
适应症
干预措施
相关药物
试验速览
- 阶段
- 不适用
- 入组人数
- 100
- 主要终点
- Evaluate the effect of DAADs on covid -19
研究概览
简要总结
Evaluate effect of DAADs on covid-19 disease.
详细描述
If Chronic HCV patients who already received DAADs are protected against covid 19 and considered to be immune or not And if DAADS can be used in ttt of covid 19
研究设计
- 研究类型
- Observational
- 观察模型
- Case Control
- 时间视角
- Retrospective
入排标准
- 年龄范围
- 18 Years 至 70 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •HCV patient with or without LC.
- •>18 years old.
- •Received DAADs at 2019.
排除标准
- •Combined HCV and HIV infected patients.
- •Combined HCV and HBV infected patients.
- •< 18 years old.
- •Pregnant or breast-feeding patients.
- •Patients with autoimmune disease.
- •Patients with multiorgan failure, active cancer, renal insufficiency.
- •Patients received immunosuppressive drugs.
- •Immune compromised patients.
- •Previous confirmed diagnosis of SARS-CoV-2 before starting DAAs.
研究组 & 干预措施
Chronic HCV patients previously treated by DAADs.
干预措施: DAAD Compound (Drug)
结局指标
主要结局
Evaluate the effect of DAADs on covid -19
时间窗: 12 months (from 1/2/2021 to 1/2/2022)
If chronic HCV patients who received DAADs suspected to be infected by covid-19 by having findings suggest covid 19 infection in MSCT chest or clinically symptoms or confirmed by nasopharyngeal swab . And if infected what about severity , if they need hospital admission or oxygen therapy or mechanical ventilation ,if they still alive or died
次要结局
未报告次要终点
研究者
相似试验
已完成
4 期
HCV Related Hepatocellular Carcinoma Recurrence After Directly Acting Antivirals: A Randomized Controlled TrialNeoplasm RecurrenceTreatment ComplicationHepatocellular CarcinomaHepatitis CNCT04653818Alexandria University84
Unknown
不适用
Impact of DAA Uptake in Controlling HCV Epidemic and Modeling Interventions for HCV Elimination Among HIV-infected Persons in San DiegoHepatitis C, ChronicHIV/AIDSHepatitis CNCT03551002University of California, San Diego450
已完成
不适用
Antiviral Drugs on the Treatment of SARS-CoV-2Complication of Medical CarePneumonia, ViralNCT04727775Astana Medical University150
已完成
不适用
Current Treatment of HCV Infection After HSCTHepatitis CNCT03014986European Society for Blood and Marrow Transplantation46
Unknown
不适用
Quality of Life in Patients With HCV Related Liver Cirrhosis Before and After Direct Acting Antiviral DrugsHCV Related Liver Cirrhosis Direct Acting Antiviral DrugsNCT03897608Assiut University50